The effectiveness of glucocorticoid treatment in post-COVID-19 pulmonary involvement
Abstract Rationale Persistent respiratory symptoms following Coronavirus Disease 2019 (COVID-19) are associated with residual radiological changes in lung parenchyma, with a risk of development into lung fibrosis, and with impaired pulmonary function. Previous studies hinted at the possible efficacy...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
BMC
2024-02-01
|
| Cyfres: | Pneumonia |
| Pynciau: | |
| Mynediad Ar-lein: | https://doi.org/10.1186/s41479-023-00123-7 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
